Clinical Trial Update: Study of Topical Ocular PAN-90806 in PDR [Phase 1]

View source ↗

Summary

Phase 1 study of topical PAN-90806 for diabetic retinopathy (including proliferative diabetic retinopathy) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Retinopathy
• Proliferative Diabetic Retinopathy

Drugs mentioned

• PAN-90806

Snippet

Sponsor: PanOptica, Inc. | Conditions: Diabetic Retinopathy | Phase 1 | Status: COMPLETED